Analyst Ratings for Lexicon Pharmaceuticals (LXRX)
LXRX Rating Summary
LXRX Price Target Summary
- Highest: $8.00 (Citi)
- Lowest: $3.00 (Jefferies)
- Average: $5.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.50 (+340%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Avg. $ Target:
$5.50 (+340%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/7/2023 | Jefferies | Andrew Tsai | New Coverage | Hold (N/A) |
3.00 (N/A) |
2.68 (1.25) |
-53.36% | Details |
| 8/12/2022 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
10.00 (N/A) |
2.78 (1.25) |
-55.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
